Events

RSA Inspiring Leaders Webinar w/ Jackie Hunter

In this webinar, participants will hear from four distinguished industry leaders with inspiring stories.

They will share insights on the experiences, people and decisions that shaped their successful careers, talking about what constitutes great leadership and how that contributes to innovative, breakthrough science.

Speakers
  • Jo Pisani, Non-Executive Director, The RSA Group
  • Dr. Niven R Narain, Co-founder, President & CEO, BERG
  • Prof. Jackie Hunter, Board Director BenevolentAI
  • Shiva Dustdar, Head of Division, Innovation Finance Advisory for the European Investment Bank
Who Should Attend?

Senior professionals who are:

  • Aspiring and existing leaders from any sector or background
  • Life science executives searching for leadership advice
  • Women in leadership looking for guidance and role models
  • C-suite professionals
What You Will Learn

In this webinar, participants will gain:

  • Advice from the experts on what good, effective, inclusive leadership means
  • How to achieve this leadership and the mindset needed to lead well
  • Insights on building resilience, facing adversity, embracing your differences and being confident
  • An understanding of why diversity is vital to success
  • Advice that leaders from any industry sector would gain incredible value from
Register here →


Jackie Hunter

Board Director of BenevolentAI

Jackie Hunter is a Board Director of BenevolentAI.  Jackie has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation and most recently was Chief Executive of the Biotechnology and Biological Sciences Research Council. She holds a personal chair from St George's Hospital Medical School, which was awarded in recognition of her contribution to bioscience research. In 2010 she was awarded a CBE in the Queen's Birthday Honours list for Services to the Pharmaceutical Industry.

More Posts

You Might Also Like

News
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
AstraZeneca selects another novel target for idiopathic pulmonary fibrosis from the collaboration for its drug development portfolio.
May 17, 2022
Blog
FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval
The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
May 12, 2022
News
Notifications of persons discharging managerial responsabilities
May 5, 2022
News
PDMR Notification (Dr. Olivier Brandicourt)
May 5, 2022
News
PDMR Notification (Jean Raby)
May 5, 2022
News
Notifications of Major Holdings
Apr 29, 2022